BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27815289)

  • 1. Long-term Prediction of Cardiovascular Outcomes by Circulating CD34+ and CD34+CD133+ Stem Cells in Patients With Type 2 Diabetes.
    Fadini GP; Rigato M; Cappellari R; Bonora BM; Avogaro A
    Diabetes Care; 2017 Jan; 40(1):125-131. PubMed ID: 27815289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low CD34+ cell count and metabolic syndrome synergistically increase the risk of adverse outcomes.
    Fadini GP; de Kreutzenberg S; Agostini C; Boscaro E; Tiengo A; Dimmeler S; Avogaro A
    Atherosclerosis; 2009 Nov; 207(1):213-9. PubMed ID: 19406403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating Concentrations of Redox Biomarkers Do Not Improve the Prediction of Adverse Cardiovascular Events in Patients With Type 2 Diabetes Mellitus.
    Cournot M; Burillo E; Saulnier PJ; Planesse C; Gand E; Rehman M; Ragot S; Rondeau P; Catan A; Gonthier MP; Feigerlova E; Meilhac O; Hadjadj S
    J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29478972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating endothelial progenitor cells and cardiovascular outcomes.
    Werner N; Kosiol S; Schiegl T; Ahlers P; Walenta K; Link A; Böhm M; Nickenig G
    N Engl J Med; 2005 Sep; 353(10):999-1007. PubMed ID: 16148285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progenitor Cells and Clinical Outcomes in Patients With Heart Failure.
    Samman Tahhan A; Hammadah M; Sandesara PB; Hayek SS; Kalogeropoulos AP; Alkhoder A; Mohamed Kelli H; Topel M; Ghasemzadeh N; Chivukula K; Ko YA; Aida H; Hesaroieh I; Mahar E; Kim JH; Wilson P; Shaw L; Vaccarino V; Waller EK; Quyyumi AA
    Circ Heart Fail; 2017 Aug; 10(8):. PubMed ID: 28790053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mediterranean, but not lacto-ovo-vegetarian, diet positively influence circulating progenitor cells for cardiovascular prevention: The CARDIVEG study.
    Cesari F; Dinu M; Pagliai G; Rogolino A; Giusti B; Gori AM; Casini A; Marcucci R; Sofi F
    Nutr Metab Cardiovasc Dis; 2019 Jun; 29(6):604-610. PubMed ID: 30952572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular safety for once-weekly dulaglutide in type 2 diabetes: a pre-specified meta-analysis of prospectively adjudicated cardiovascular events.
    Ferdinand KC; Botros FT; Atisso CM; Sager PT
    Cardiovasc Diabetol; 2016 Feb; 15():38. PubMed ID: 26912057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Change in Circulating Progenitor Cells During Exercise Stress and Risk of Adverse Cardiovascular Events in Patients With Coronary Artery Disease.
    Moazzami K; Lima BB; Hammadah M; Ramadan R; Al Mheid I; Kim JH; Alkhoder A; Obideen M; Levantsevych O; Shah A; Liu C; Bremner JD; Kutner M; Sun YV; Waller EK; Hesaroieh IG; Raggi P; Vaccarino V; Quyyumi AA
    JAMA Cardiol; 2020 Feb; 5(2):147-155. PubMed ID: 31799987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating progenitor and angiogenic cell frequencies are abnormally static over pregnancy in women with preconception diabetes: A pilot study.
    Lima PD; Chen Z; Tayab A; Murphy MS; Pudwell J; Smith GN; Croy BA
    PLoS One; 2017; 12(3):e0172988. PubMed ID: 28278173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different subpopulations of endothelial progenitor cells and circulating apoptotic progenitor cells in patients with vascular disease and diabetes.
    Jung C; Rafnsson A; Shemyakin A; Böhm F; Pernow J
    Int J Cardiol; 2010 Sep; 143(3):368-72. PubMed ID: 19398138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating endothelial progenitor cells in type 1 diabetic patients with erectile dysfunction.
    Maiorino MI; Bellastella G; Petrizzo M; Della Volpe E; Orlando R; Giugliano D; Esposito K
    Endocrine; 2015 Jun; 49(2):415-21. PubMed ID: 25411101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating CD34+ KDR+ endothelial progenitor cells correlate with erectile function and endothelial function in overweight men.
    Esposito K; Ciotola M; Maiorino MI; Giugliano F; Autorino R; De Sio M; Jannini E; Lenzi A; Giugliano D
    J Sex Med; 2009 Jan; 6(1):107-14. PubMed ID: 19170841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Progenitor Cells and Racial Differences.
    Samman Tahhan A; Hammadah M; Kelli HM; Kim JH; Sandesara PB; Alkhoder A; Kaseer B; Gafeer MM; Topel M; Hayek SS; O'Neal WT; Obideen M; Ko YA; Liu C; Hesaroieh I; Mahar E; Vaccarino V; Waller EK; Quyyumi AA
    Circ Res; 2018 Aug; 123(4):467-476. PubMed ID: 29930146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating CD133+ CD34+ progenitor cells and plasma stromal-derived factor-1alpha: predictive role in ischemic stroke patients.
    Chen Y; Lu B; Wang J; Chen S; Lin Z; Ma X; Liu Y; Zhao B; Chen Y
    J Stroke Cerebrovasc Dis; 2015 Feb; 24(2):319-26. PubMed ID: 25444027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remote ischemic preconditioning immediately before percutaneous coronary intervention does not impact myocardial necrosis, inflammatory response, and circulating endothelial progenitor cell counts: a single center randomized sham controlled trial.
    Prasad A; Gössl M; Hoyt J; Lennon RJ; Polk L; Simari R; Holmes DR; Rihal CS; Lerman A
    Catheter Cardiovasc Interv; 2013 May; 81(6):930-6. PubMed ID: 22517646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Progenitor Cell Count Predicts Microvascular Outcomes in Type 2 Diabetic Patients.
    Rigato M; Bittante C; Albiero M; Avogaro A; Fadini GP
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2666-72. PubMed ID: 25942480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced circulating stem cells associate with excess fasting and post-load NEFA exposure in healthy adults with normal glucose tolerance.
    Fadini GP; Tura A; Pacini G; Avogaro A; Vigili de Kreutzenberg S
    Atherosclerosis; 2017 Jun; 261():117-123. PubMed ID: 28298252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating CD34+ progenitor cells and risk of mortality in a population with coronary artery disease.
    Patel RS; Li Q; Ghasemzadeh N; Eapen DJ; Moss LD; Janjua AU; Manocha P; Kassem HA; Veledar E; Samady H; Taylor WR; Zafari AM; Sperling L; Vaccarino V; Waller EK; Quyyumi AA
    Circ Res; 2015 Jan; 116(2):289-297. PubMed ID: 25323857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow-derived progenitor cells in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.
    Pescini F; Cesari F; Giusti B; Sarti C; Zicari E; Bianchi S; Dotti MT; Federico A; Balestrino M; Enrico A; Gandolfo C; Gori AM; Abbate R; Pantoni L; Inzitari D
    Stroke; 2010 Feb; 41(2):218-23. PubMed ID: 20035077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral blood CD34+KDR+ endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population.
    Fadini GP; Coracina A; Baesso I; Agostini C; Tiengo A; Avogaro A; de Kreutzenberg SV
    Stroke; 2006 Sep; 37(9):2277-82. PubMed ID: 16873710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.